bluebird bio, Inc. Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 1,000 | 2,086 | 15,271 | |
| Mar 28 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,000 | 4,173 | 16,271 | |
| Mar 28 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 90.00 | 1,000 | 90,000 | 1,400 | 2.4 K to 1.4 K (-41.67 %) |
| Mar 28 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 1,000 | 2,086 | 2,400 | 1.4 K to 2.4 K (+71.43 %) |
| Mar 28 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 87.63 | 300 | 26,290 | 1,400 | 1.7 K to 1.4 K (-17.65 %) |
| Mar 28 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 87.10 | 1,700 | 148,067 | 1,700 | 3.4 K to 1.7 K (-50.00 %) |
| Mar 28 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,000 | 4,173 | 3,400 | 1.4 K to 3.4 K (+142.86 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 266 | 1,463 | 91,885 | |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 2.09 | 3,277 | 6,849 | 15,236 | |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 100.07 | 3,543 | 354,563 | 27,305 | 30.8 K to 27.3 K (-11.49 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 266 | 1,463 | 30,848 | 30.6 K to 30.8 K (+0.87 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 2.09 | 3,277 | 6,849 | 30,582 | 27.3 K to 30.6 K (+12.00 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 99.00 | 411 | 40,689 | 6,466 | 6.9 K to 6.5 K (-5.98 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 237 | 494 | 18,271 | |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 100.07 | 237 | 23,718 | 1,400 | 1.6 K to 1.4 K (-14.48 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 237 | 494 | 1,637 | 1.4 K to 1.6 K (+16.93 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 22.53 | 4,930 | 111,073 | 55,632 | |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 100.07 | 4,930 | 493,366 | 12,051 | 17 K to 12.1 K (-29.03 %) |
| Mar 20 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 22.53 | 4,930 | 111,073 | 16,981 | 12.1 K to 17 K (+40.91 %) |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 5.50 | 12,917 | 71,049 | 0 | |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 0.95 | 922 | 874 | 0 | |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 85.02 | 13,839 | 1,176,646 | 4,843 | 18.7 K to 4.8 K (-74.08 %) |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 5.50 | 12,917 | 71,049 | 18,682 | 5.8 K to 18.7 K (+224.06 %) |
| Mar 06 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 0.95 | 922 | 874 | 5,765 | 4.8 K to 5.8 K (+19.04 %) |
| Mar 03 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,000 | 4,173 | 18,508 | |
| Mar 03 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 90.32 | 2,000 | 180,636 | 1,400 | 3.4 K to 1.4 K (-58.82 %) |
| Mar 03 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,000 | 4,173 | 3,400 | 1.4 K to 3.4 K (+142.86 %) |
| Mar 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 2.09 | 5,000 | 10,450 | 18,239 | |
| Mar 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 90.32 | 3,000 | 270,954 | 17,177 | 20.2 K to 17.2 K (-14.87 %) |
| Mar 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 89.35 | 2,000 | 178,690 | 20,177 | 22.2 K to 20.2 K (-9.02 %) |
| Mar 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 2.09 | 5,000 | 10,450 | 22,177 | 17.2 K to 22.2 K (+29.11 %) |
| Mar 02 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 89.00 | 285 | 25,365 | 6,877 | 7.2 K to 6.9 K (-3.98 %) |